Glaucoma
Glaucoma is an eye disease that causes damage to nerve fibers and the optic nerve, leading to the loss of the visual field.
Several studies have shown that preserved glaucoma medication can lead to additional complaints, such as dry eyes.1 That is why we have unpreserved eye drops available for the treatment of glaucoma. These are intended to lower the eye pressure.
1 J.A.P. Gomes et al. / The Ocular Surface xxx (2017) 516-543, TFOS DEWS II iatrogenic report, P. 519, 4.2.1. Incidence and prevalence
Products
-
Bimatoprost
Bimatoprost Stulln 0.3 mg/ml is an unpreserved eye drop in a multidose bottle.
The therapeutic indication of Bimatoprost Stulln is reduction of increased intraocular pressure in chronic open
Angle glaucoma and ocular hypertension in adults (as monotherapy or as an adjunctive treatment with beta-blockers).Bimatoprost Stulln 0.3 mg/ml, an unpreserved eye drop in a multidose bottle.
-
Brimonidine
This preservative-free medicine is used to lower the eye pressure. It can be used in the treatment of open-angle glaucoma or ocular hypertension. Both conditions involve increased pressure in your eye.
It can be used as a single medicine only when eye drops containing beta-blockers (certain group of medicines for high blood pressure, certain heart conditions and increased eye pressure) cannot be used by you. It can also be used with another eye drop when one medicine isn’t enough to lower the raised pressure in the eye.
-
Dorzolamide + Timolol
Dorzolamide + Timolol Stulln without preservative contains two ingredients: dorzolamide and timolol. Dorzolamide belongs to a group of medicines called ‘carbonic anhydrase inhibitors’. Timolol belongs to a group of medicines called ‘beta blockers’. These ingredients both lower eye pressure in different ways.
This drug is prescribed to glaucoma patients who wish to lower eye pressure in the treatment of glaucoma, when using an eye drop containing a beta-blocker alone, is not enough.